The Patient-Centered Outcomes Research Institute (PCORI) has selected Cleveland Clinic for a nationwide initiative to improve how healthcare systems translate research findings to clinical practice. The initiative aims to reduce the time it takes to move discovery in research to new treatments, with an estimated lag of 17 years.
A new screening tool developed by Cleveland Clinic researchers can effectively detect mild cognitive impairment, early Alzheimer's disease, and other related dementias in older adults. The tool has been shown to identify 90% of patients with mild cognitive impairment, offering a potential solution for early detection and prevention.
A new study by the Cleveland Clinic found that high levels of erythritol, a popular artificial sweetener, are associated with an increased risk of heart attack and stroke. Researchers studied over 4,000 people and found those with higher blood erythritol levels were at elevated risk of experiencing a major adverse cardiac event.
The Cleveland Clinic has launched a phase 1b clinical trial to evaluate the safety and immune response of a preventive breast cancer vaccine in high-risk individuals who have undergone prophylactic mastectomy. The study aims to recruit 6-12 patients and is expected to be completed by the end of 2023.
A new prostate cancer therapy is being tested in clinical trials, targeting the treatment-resistant form of the disease. The therapy uses a drug called Abivertinib to block a specific protein that allows tumors to produce androgens, a goal of using more targeted treatments like TKIs.
A new system will prioritize medical needs over geographical location for lung transplant candidates. The change is expected to reduce waitlist mortality and improve post-transplant survival.
Researchers found genetic mutations to OAS and RNase L proteins increase inflammatory response in immune cells, leading to MIS-C. This understanding may provide clues to chronic inflammation diseases like Kawasaki disease.
A massive international data analysis uncovered hundreds of signals for new treatment and prevention targets in colorectal cancer. The study identified 250 independent risk associations, including 50 newly discovered ones, through analyzing genomic, transcriptomic, and methylomic data.
Researchers at Cleveland Clinic found that elevated levels of phenylacetylglutamine, a byproduct of gut microbiome breakdown, increase heart failure risk and severity. This discovery suggests potential approaches to modify PAG-associated risks through diet and beta blocker use.
The Cleveland Clinic is developing a stem cell treatment for complex regional pain syndrome, a debilitating disease that causes chronic pain, using human mesenchymal stem cells (hMSC). The research has long-term potential for providing patients an alternative to addictive opioid treatments.
Researchers analyzed a child's genetic data to identify novel mutations in the GTF3A gene, which impair the innate immune response. The study found that these mutations make cells more susceptible to HSV-1 infection and loss of antiviral immune response.
Research suggests that antibiotics used in ovarian cancer treatment can accelerate cancer progression and lower survival rates. Reintroducing healthy gut bacteria may slow down cancer growth and restore sensitivity to chemotherapy.
A new study published in Alzheimer's & Dementia found that telmisartan, a blood pressure medication, is associated with lower risk of Alzheimer's specifically in Black patients over 60. The study analyzed data from over 5 million patients and suggests that future clinical trials should prioritize minority populations to find or reinfor...
Researchers at Cleveland Clinic are exploring the role of inflammatory cytokines in cancer treatment, with a focus on developing personalized therapies. The five-year grant will help identify potential windows for therapy and optimize treatment strategies for individual cancers.
Researchers found that metformin targeted 30 genes associated with atrial fibrillation, showing direct effects on gene expression for eight. The study suggests metformin may be a promising candidate for treating atrial fibrillation due to its potential to reduce the risk of complications such as stroke and heart failure.
A Cleveland Clinic-led research team created a discovery tool outlining interactions between COVID-19 and host proteins, identifying potential host-targeting therapies. The study confirmed over 200 interactions and discovered new ones, highlighting promising approaches for treating COVID-19.
The National Institutes of Health has awarded a $10.7 million grant to Cleveland Clinic to expand a national research consortium focused on improving diagnosis and treatments for Dementia with Lewy Bodies. The consortium, which includes multiple clinical sites, aims to identify biomarkers for disease and develop new therapies.
Researchers at Cleveland Clinic's FRIC found that cytoskeleton disruption is a key signal for the body to respond to viruses. This discovery has potential implications for developing new anti-viral vaccines and treatments.
Researchers at Cleveland Clinic link HSD3B1 genotype to higher risk of type 2 endometrial cancer, which is more aggressive and has lower survival rates than type 1. The study builds on previous associations with breast and prostate cancer, suggesting the gene could serve as a biomarker for certain subtypes.
The American Heart Association offers important guidance on sleep-disordered breathing and its association with cardiac arrhythmia, highlighting the potential benefits of SDB treatment on patient outcomes. The statement emphasizes the need for more randomized data to confirm the link between SDB and reduced atrial fibrillation recurrence.
Researchers analyzed genomic data from 44 women with germline PTEN mutations who developed breast cancer and compared it to sporadic breast cancers. They found that PTEN and PIK3CA were the most frequently somatically mutated genes in PHTS-associated breast cancers, indicating that somatic mutations in PTEN drive these cancers.
Researchers at Cleveland Clinic discovered that pathogenic POLE/POLD1 genetic mutations in tumors lead to a high level of immune cell infiltration and improved response to immune checkpoint blockade therapy. The study's findings contribute to the growing list of discoveries that prove certain classes of drugs are more effective based o...
Researchers have found that tumor cells co-exist with normal tissue in a complex, heterogeneous mixture, leading to unexpected effects on therapeutic resistance. The study suggests that understanding these ecological interactions could lead to novel treatment strategies and improved patient outcomes.
Researchers found high mortality rates in the Midwest/northeastern Great Lakes region and lower risk counties in western/southwestern areas. The study highlights regions warranting further investigation and preventive interventions to address the increasing burden of young-onset colorectal cancer.
A Cleveland Clinic study found that bariatric surgery significantly reduces the risk of developing obesity-associated cancers and dying from cancer. The research, published in JAMA, showed a 32% lower risk of cancer development and a 48% lower risk of cancer-related death compared to non-surgical controls.
A recent study published in mBio discovered that the SARS-CoV-2 viral gene ORF8 plays a crucial role in the severity and spread of COVID-19. Researchers found that mutations in ORF8 contribute to inflammation and disease outcomes, suggesting new treatment options for patients with severe cases.
A Cleveland Clinic-led trial found that an experimental 'gene silencing' therapy significantly reduced blood levels of lipoprotein(a), a key driver of heart disease risk, by up to 96%-98%. The therapy targets the gene responsible for Lp(a) production and has shown strong efficacy with no major safety concerns reported.
The trial evaluated the use of mavacamten as an alternative to heart surgery or alcohol septal ablation for treating hypertrophic cardiomyopathy. Findings showed significant reduction in left ventricular outflow tract pressure gradient and improvements in quality-of-life measures.
A Cleveland Clinic study found that standardizing care led to more equitable COVID-19 outcomes in the ICU, despite existing health disparities among racial and ethnic groups. The study revealed Black patients had a higher prevalence of asthma, diabetes, and hypertension, increasing their risk of severe COVID-19 cases.
A Cleveland Clinic study found that prior weight loss achieved with bariatric surgery was associated with a 60% lower risk of developing severe COVID-19. Patients who underwent weight-loss surgery had better clinical outcomes, including reduced hospitalization and need for supplemental oxygen.
Cleveland Clinic researchers have identified the gut microbial gene cluster responsible for converting carnitine into TMAO, which promotes heart disease and stroke. The study found that dietary modifications may help reduce diet- and TMAO-associated cardiovascular disease risk by targeting the gbu gene cluster.
The study, published in Nature Aging, found that sildenafil reduces the likelihood of developing Alzheimer's disease by 69% compared to non-users. Sildenafil also shows promise in treating the disease by increasing brain cell growth and decreasing hyperphosphorylation of tau proteins.
Researchers found that COVID-19 infection in mothers leads to distinct immune changes in babies, including altered cytokine profiles and T cell responses. The study also identified potential correlations with clinical complications such as preeclampsia and fetal growth restriction.
Cleveland Clinic researchers found that verubecestat, an Alzheimer's disease treatment, reduces glioblastoma progression by reprogramming tumor-associated macrophages into tumor-suppressing macrophages. This transformation leads to increased phagocytosis of tumor cells and reduced tumor growth.
A Cleveland Clinic study shows that bariatric surgery significantly lowers the risk of progression to cirrhosis, liver cancer, or liver-related death. Bariatric surgery also reduces the risk of developing serious cardiovascular diseases such as heart attack and stroke.
A new Cleveland Clinic study found that patients with certain sleep disorders have a 31% higher rate of hospitalization and mortality from COVID-19. The research team analyzed retrospective data from 5,400 patients and found that sleep-related hypoxia translates to worse COVID-19 outcomes.
A new machine learning model developed by Timothy Chan accurately predicts whether immune checkpoint blockade will be effective in patients with various cancers. The tool assesses multiple patient-specific factors, including tumor mutational burden and chemotherapy history, to predict response and survival outcomes.
Researchers found diet-associated molecules in the gut are associated with aggressive prostate cancer, linking them to higher levels of metabolites like phenylacetylglutamine and nutrients choline and betaine. The study's findings may have clinical implications for diagnosing and preventing lethal prostate cancer.
Researchers have opened a novel study for a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease. The phase I trial will determine the maximum tolerated dose of the vaccine in patients with early-stage triple-negative breast cancer.
A first-in-human study at Cleveland Clinic found that targeting the dentate nucleus with deep brain stimulation was safe and feasible for promoting post-stroke rehabilitation, enabling significant functional improvement in upper extremity hemiparesis. The study's adaptive design allowed for extended treatment duration if patients conti...
Dr. Gack's research focuses on identifying broad-spectrum antiviral drug targets and has implications for developing effective treatments against COVID-19 and other viral threats. The $5.6 million NIH grant will support her investigation into targeting human enzymes essential for virus replication.
A recent Cleveland Clinic study found that patients who use steroid nasal sprays are less likely to develop severe COVID-19-related disease, including lower risk of hospitalization, ICU admission, and mortality. The study showed a 20-25% reduction in these outcomes for patients using intranasal corticosteroids.
A Cleveland Clinic-led research team found that statistically overweight children who followed a healthy eating pattern significantly improved weight and reduced various cardiovascular disease risks. The study also showed improvements in blood pressure, total cholesterol, and low-density lipoprotein levels.
A new surgical procedure called Kareem's procedure has been introduced to treat congenital intestinal malrotation, a condition where the intestines twist, causing serious complications. The study shows favorable outcomes in patients with intact gut and disabling symptoms, with significant improvement in digestive symptoms after surgery.
Researchers created a bionic arm that combines intuitive motor control with touch and hand movement sensation, enabling wearers to think and behave like a person without an amputation. The system's bi-directional feedback and control allowed study participants to perform tasks with similar accuracy as non-disabled people.
Researchers from Cleveland Clinic have published results showing that Temporally Feathered Radiation Therapy (TFRT) is a safe and feasible approach to reduce toxicity in radiation treatment. The technique optimizes radiation delivery time to improve normal tissue recovery, potentially improving patient quality of life.
The Cleveland Alzheimer’s Disease Research Center will receive funding to accelerate research on Alzheimer’s disease and related dementias. The center aims to develop individualized treatment approaches for individuals with aging-associated brain disorders.
Patients who underwent bariatric surgery reported improved physical health, energy, and reduced body pain compared to those on medical therapy alone. Significant weight loss and insulin independence drove these improvements in general health measures and quality of life.
A study published in Annals of Neurology found the SNCA gene has genome-wide significance in Latino PD patients, while a novel gene NRROS is identified as a potential risk factor. The research also shows a substantial overlap of PD genetic architecture between Europeans and Latinos.
A study by Cleveland Clinic found that combining a weight management program with FDA-approved anti-obesity medications leads to significant weight loss among adults with obesity. The research showed that participants who had access to the medications averaged -7.7% weight loss at 12 months, compared to -4.2% in those without medication.